FDA now offers preliminary advice on whether a product in development could warrant a breakthrough designation, another seemingly lesser-known attempt at limiting the burden of reviewing formal requests to be part of the program.
Sponsors considering applying for a breakthrough designation request now can ask for "preliminary breakthrough